Cynvenio is the pioneer in LiquidBiopsy® technology for the genomic analysis of tumor cells from whole blood in support of cancer precision medicine strategies.

 
  LiquidBiopsy ®  Platform   An automated rare cell isolation and staining front-end for all types of molecular characterization, especially sequencing.   Learn More →

LiquidBiopsy® Platform

An automated rare cell isolation and staining front-end for all types of molecular characterization, especially sequencing.

Learn More →

  LiquidBiopsy ®  Testing   A risk-free, painless method to dynamically sample study participants and sequentially measure response to treatment.   Learn More →

LiquidBiopsy® Testing

A risk-free, painless method to dynamically sample study participants and sequentially measure response to treatment.

Learn More →